Oscar Health, Inc. (NYSE:OSCR) Shares Acquired by Swiss National Bank

Swiss National Bank raised its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 17.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 314,900 shares of the company's stock after purchasing an additional 47,500 shares during the quarter. Swiss National Bank owned about 0.13% of Oscar Health worth $6,679,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Price T Rowe Associates Inc. MD grew its position in Oscar Health by 153.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company's stock worth $59,156,000 after buying an additional 2,409,160 shares during the period. Renaissance Technologies LLC raised its holdings in Oscar Health by 31.7% during the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company's stock worth $61,478,000 after purchasing an additional 934,600 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Oscar Health during the 2nd quarter worth $14,716,000. Bank of New York Mellon Corp boosted its position in shares of Oscar Health by 161.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company's stock worth $22,038,000 after buying an additional 860,226 shares in the last quarter. Finally, Beck Bode LLC purchased a new stake in shares of Oscar Health in the 1st quarter worth about $9,856,000. 75.70% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CAO Victoria Baltrus sold 4,226 shares of the company's stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $76,025.74. Following the sale, the chief accounting officer now directly owns 140,648 shares of the company's stock, valued at $2,530,257.52. This represents a 2.92 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Mario Schlosser sold 3,198 shares of the stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 3.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have bought 1,055,478 shares of company stock worth $14,432,852 and have sold 194,569 shares worth $3,433,319. 25.11% of the stock is currently owned by company insiders.

Oscar Health Trading Up 3.4 %

OSCR traded up $0.56 on Wednesday, reaching $16.84. 1,922,375 shares of the company's stock were exchanged, compared to its average volume of 3,417,110. Oscar Health, Inc. has a twelve month low of $7.29 and a twelve month high of $23.79. The company's 50 day moving average is $17.57 and its 200-day moving average is $18.10. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market cap of $4.16 billion, a price-to-earnings ratio of -280.62 and a beta of 1.67.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to analysts' expectations of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The company's revenue for the quarter was up 68.3% compared to the same quarter last year. During the same period last year, the business earned ($0.29) earnings per share. Equities analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

OSCR has been the topic of a number of recent research reports. Piper Sandler reaffirmed an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group assumed coverage on Oscar Health in a research note on Monday, October 7th. They set a "neutral" rating and a $23.00 price objective on the stock. Finally, Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and cut their target price for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Oscar Health presently has an average rating of "Moderate Buy" and an average target price of $22.93.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.